Prednisolone withdrawal therapy enhances the effect of human lymphoblastoid interferon in chronic hepatitis B

This publication has 24 references indexed in Scilit:

• The treatment effect of alpha interferon in chronic hepatitis B is independent of pre-treatment variables. Results based on individual patient data from 10 clinical controlled trials
  Journal of Hepatology, 1994
• A controlled trial of interferon with or without prednisone priming for chronic hepatitis B
  Gastroenterology, 1992
• A Controlled Trial of Recombinant Interferon-Alpha in Caucasian Children with Chronic Hepatitis B
  Digestion, 1990
• Which Patients With Chronic Hepatitis B Virus Infection Will Respond to α–Interferon Therapy? A Statistical Analysis of Predictive Factors
  Hepatology, 1989
• Randomised controlled trial of lymphoblastoid interferon alfa in Europid men with chronic hepatitis B virus infection.
  BMJ, 1989
• A controlled trial of human lymphoblastoid interferon in chronic hepatitis B in Italy
  Hepatology, 1989
• Randomised controlled trial of interferon alfa 2A (rbe) (Roferon-A) for the treatment of chronic hepatitis B virus (HBV) infection: factors that influence response.
  Gut, 1989
• Randomized, controlled trial of recombinant human α-interferon in patients with chronic hepatitis B
  Gastroenterology, 1988
• LONG-TERM FOLLOW-UP IN A RANDOMISED CONTROLLED TRIAL OF RECOMBINANT α2-INTERFERON IN CHINESE PATIENTS WITH CHRONIC HEPATITIS B INFECTION
  The Lancet, 1988
• RAPID WITHDRAWAL OF IMMUNOSUPPRESSIVE THERAPY IN CHRONIC ACTIVE HEPATITIS B INFECTION
  The Lancet, 1981